Acura Pharmaceuticals (ACUR)
Add to Watchlists Create an Alert
2.37
+0.01 +0.42%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Acura Pharmaceuticals Revenue Quarterly YoY Growth
Acura Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 30, 2012 | -100.0% |
| March 31, 2012 | -100.0% |
| Dec. 31, 2011 | -100.0% |
| Sept. 30, 2011 | -100.0% |
| June 30, 2011 | 3163% |
| March 31, 2011 | -88.58% |
| Dec. 31, 2010 | -52.13% |
| Sept. 30, 2010 | -63.86% |
| June 30, 2010 | -30.88% |
| March 31, 2010 | 47.83% |
| Dec. 31, 2009 | -90.37% |
| Sept. 30, 2009 | -79.18% |
| June 30, 2009 | -94.28% |
| March 31, 2009 | -91.92% |
| Dec. 31, 2008 | |
| Sept. 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
| June 30, 2000 | Go Pro |
| March 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
ACUR Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Durect Corporation | -89.92% |
| Pain Therapeutics | -34.14% |
| Pfizer | -9.30% |
ACUR Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -100.0% | Sep 2011 |
| Maximum | 3163% | Jun 2011 |
| Average | 158.6% |
